Allens has advised SK Group on the sale of a majority stake in Imexpharm Corporation (IMP), a leading Vietnamese pharmaceutical company listed on the Ho Chi Minh Stock Exchange, to Lian SGP Holding Pte. Ltd. (a 100% subsidiary of Livzon Pharmaceutical Group) via a public tender offer process.
This transaction is a rare majority stake sale of a listed Vietnamese company by a foreign strategic shareholder. Allens drew on its extensive experience in Vietnam to assist SK Group with all the transaction's aspects, and worked closely with its global alliance firm, Linklaters, on the Singaporean and Chinese law aspects.
'We are pleased to once again support SK Group on this important transaction as part of its broader strategy to restructure its investment portfolio in Vietnam. This marks another significant milestone in our longstanding relationship with SK, following our work on SK's investment in Masan Group, Vingroup and Pharmacity', said Partner Linh Bui.
